This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Mettler-Toledo (MTD)

Tipranks - Tipranks - Tue May 12, 10:04AM CDT

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Pfizer (PFE) and Mettler-Toledo (MTD) with bullish sentiments.

Claim 55% Off TipRanks

Pfizer (PFE)

In a report released today, Evan Seigerman from BMO Capital maintained a Buy rating on Pfizer, with a price target of $34.00. The company’s shares closed last Monday at $26.08.

According to TipRanks.com, Seigerman is a 4-star analyst with an average return of 7.4% and a 50.5% success rate. Seigerman covers the Healthcare sector, focusing on stocks such as Structure Therapeutics, Inc. Sponsored ADR, Vertex Pharmaceuticals, and ACADIA Pharmaceuticals. ;'>

Currently, the analyst consensus on Pfizer is a Moderate Buy with an average price target of $29.22, which is a 13.3% upside from current levels. In a report issued on April 27, Evercore ISI also maintained a Buy rating on the stock.

See Insiders’ Hot Stocks on TipRanks >>

Mettler-Toledo (MTD)

In a report released today, Michael Ryskin from Bank of America Securities maintained a Buy rating on Mettler-Toledo. The company’s shares closed last Monday at $1115.71.

According to TipRanks.com, Ryskin is a 2-star analyst with an average return of 0.4% and a 48.1% success rate. Ryskin covers the Healthcare sector, focusing on stocks such as West Pharmaceutical Services, Caris Life Sciences, Inc., and Tempus AI, Inc. Class A. ;'>

Mettler-Toledo has an analyst consensus of Moderate Buy, with a price target consensus of $1388.43, implying a 24.3% upside from current levels. In a report issued on May 8, Barclays also maintained a Buy rating on the stock with a $1500.00 price target.

Read More on PFE:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).